CureMatch: A Breakthrough Technology for Personalized Cancer Care

Navid Alipour

Navid Alipour, CEO, CureMatch Today, most oncologists know that a one-size-fits-all approach may not result in optimal cancer treatment, which can encompass chemotherapy, radiation therapy, surgery, infusions and a large number of other drugs. As recent research reveals, each patient’s cancer and the actual molecular profile of each patient’s tumor is unique in nature – […]